Apiary invests in performance.io

Apiary Capital has completed a significant investment in performance.io (PIO), the specialist provider of digital performance marketing services to the pharmaceutical industry. Apiary’s investment will support PIO’s management team to accelerate expansion in the US and Asia, as well as invest in people and technology as the company scales.

PIO is a specialist performance marketing agency focused on optimising the effectiveness of digital marketing for large pharma manufacturers, increasing organic online traffic to websites and content alongside improving patient and healthcare professional engagement. PIO combines deep pharma expertise with best-in-class, tech-enabled SEO services, positioning PIO as one of the few scaled specialists in a sector where digital marketing adoption is growing but remains significantly behind other industries.

“We are delighted to have secured the support of Apiary Capital,” said Matt Lowe, founder and CEO of PIO. “It was always critical to us to find an investment partner that had the right cultural fit and appreciated that the values we have as an organisation are key to our success. The Apiary investment will allow us to scale internationally and continue to invest in our people and technology to stay at the forefront of the exciting and rapidly changing market we operate in.”

Jess French, Investment Director at Apiary, commented: “We are incredibly excited to partner with Matt and the entire PIO team. This is exactly the kind of business Apiary seeks to invest in: founder-led, clearly differentiated, and focused on delivering real, measurable value to its clients. We look forward to supporting PIO in accelerating its ambitious growth plans.”